Adherence and persistence with taking medication to control high blood pressure

被引:106
作者
Hill, Martha N. [1 ]
Miller, Nancy Houston [2 ]
DeGeest, Sabina [3 ]
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
[2] Stanford Univ, Sch Med, Stanford Cardiac Rehabil Program, Palo Alto, CA 94304 USA
[3] Univ Basel, Inst Nursing Sci, Basel, Switzerland
关键词
Adherence; compliance; persistence; concordance; medication management; high blood pressure; hypertension; ASH position paper; HYPERTENSION TREATMENT; PATIENT ADHERENCE; UNITED-STATES; PRIMARY-CARE; ADULTS; CALL; NONADHERENCE; STRATEGIES; MANAGEMENT; AWARENESS;
D O I
10.1016/j.jash.2011.01.001
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Nonadherence and poor or no persistence with taking antihypertensive medications results in uncontrolled high blood pressure, poor clinical outcomes and preventable health care costs. Factors associated with nonadherence are multilevel and relate not only to the patient, but also to the provider, health care system, health care organization, and community. National guideline committees have called for more aggressive approaches to implement strategies known to improve adherence and technologies known to enable changes at the systems level including improved communication among providers and patients. Improvements in adherence and persistence are likely to be achieved by supporting patient self-management, a team approach to patient care, technology-supported office practice systems, better methods to measure adherence, and less clinical inertia. Integrating high blood pressure control into health care policies that emphasize and improve prevention and management of chronic illness remains a challenge. Four strategies are proposed: focusing on clinical outcomes; empowering informed, activated patients; developing prepared proactive practice teams; and advocating for health care policy reform. With hypertension remaining the most common reason for office visits, the time is now. J Am Soc Hypertens 2011;5(1):56-63. (c) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:56 / 63
页数:8
相关论文
共 65 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[3]  
[Anonymous], 1979, JAMA-J AM MED ASSOC, V241, P2534
[4]  
[Anonymous], 2004, COCHRANE DATABASE SY
[5]  
[Anonymous], 2003, Adherence to Long-Term Therapies: Evidence for action
[6]  
[Anonymous], 1979, JAMA-J AM MED ASSOC, V242, P2572
[7]  
[Anonymous], 2007, J CLIN HYPERTENS, DOI DOI 10.1111/J.1524-6175.2007.07332.X
[8]  
[Anonymous], 1979, JAMA-J AM MED ASSOC, V242, P2562
[9]  
Antihypertensive T., 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]
[10]   Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action [J].
Bakris, G. ;
Hill, M. ;
Mancia, G. ;
Steyn, K. ;
Black, H. R. ;
Pickering, T. ;
De Geest, S. ;
Ruilope, L. ;
Giles, T. D. ;
Morgan, T. ;
Kjeldsen, S. ;
Schiffrin, E. L. ;
Coenen, A. ;
Mulrow, P. ;
Loh, A. ;
Mensah, G. .
JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (01) :63-70